BERGAMINI, Stefania
 Distribuzione geografica
Continente #
NA - Nord America 11.003
EU - Europa 10.437
AS - Asia 4.609
SA - Sud America 636
AF - Africa 68
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 11
Totale 26.784
Nazione #
US - Stati Uniti d'America 10.662
IT - Italia 4.626
GB - Regno Unito 1.883
CN - Cina 1.459
SG - Singapore 1.341
RU - Federazione Russa 1.294
SE - Svezia 860
HK - Hong Kong 742
DE - Germania 672
BR - Brasile 513
VN - Vietnam 277
CA - Canada 255
TR - Turchia 207
NL - Olanda 195
UA - Ucraina 193
FR - Francia 162
KR - Corea 143
FI - Finlandia 136
BG - Bulgaria 106
IN - India 95
ID - Indonesia 74
JP - Giappone 64
AR - Argentina 54
MX - Messico 47
IR - Iran 38
PL - Polonia 38
BE - Belgio 37
BD - Bangladesh 36
CH - Svizzera 33
ZA - Sudafrica 31
IE - Irlanda 29
MY - Malesia 29
ES - Italia 28
EC - Ecuador 25
AT - Austria 21
AU - Australia 20
CR - Costa Rica 18
DK - Danimarca 17
LT - Lituania 15
TW - Taiwan 15
AE - Emirati Arabi Uniti 14
IQ - Iraq 13
CZ - Repubblica Ceca 12
RO - Romania 12
HU - Ungheria 11
MA - Marocco 11
CL - Cile 10
EU - Europa 10
PT - Portogallo 10
DO - Repubblica Dominicana 9
LU - Lussemburgo 9
PK - Pakistan 9
CO - Colombia 8
PY - Paraguay 8
AL - Albania 7
NO - Norvegia 7
VE - Venezuela 7
AZ - Azerbaigian 6
PE - Perù 6
PH - Filippine 6
UZ - Uzbekistan 6
HN - Honduras 5
MT - Malta 5
TN - Tunisia 5
BY - Bielorussia 4
EG - Egitto 4
GR - Grecia 4
IL - Israele 4
KE - Kenya 4
SA - Arabia Saudita 4
UY - Uruguay 4
GE - Georgia 3
MD - Moldavia 3
NP - Nepal 3
PA - Panama 3
TH - Thailandia 3
AM - Armenia 2
HR - Croazia 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
MC - Monaco 2
MZ - Mozambico 2
OM - Oman 2
PS - Palestinian Territory 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CV - Capo Verde 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
Totale 26.774
Città #
Southend 1.401
Santa Clara 1.325
Moscow 1.069
Ashburn 946
Singapore 916
Fairfield 861
Chandler 795
Hong Kong 708
Woodbridge 542
Dearborn 452
Houston 444
Milan 406
Ann Arbor 400
Hefei 390
Jacksonville 389
Nyköping 389
Rome 335
Wilmington 325
Seattle 319
Beijing 288
Cambridge 270
London 269
Modena 218
Chicago 206
Ottawa 194
Los Angeles 189
New York 146
Naples 127
Seoul 127
Princeton 113
The Dalles 109
Sofia 106
Izmir 101
Eugene 95
San Diego 93
Dallas 91
Salt Lake City 77
Ho Chi Minh City 73
Hanoi 71
Bari 69
Shanghai 69
Bologna 66
Turin 65
Council Bluffs 64
Florence 61
Jakarta 59
Buffalo 57
Helsinki 55
Bremen 54
Redwood City 53
São Paulo 49
Munich 48
Genoa 46
Tokyo 43
Tampa 40
Elk Grove Village 39
Falls Church 38
Des Moines 37
Reggio Emilia 37
Palermo 35
Guangzhou 34
Parma 34
Catania 33
Columbus 32
Verona 32
Brussels 31
Boardman 29
Dublin 29
Fremont 29
Warsaw 29
Lancaster 27
Brescia 26
Kowloon 26
Toronto 26
Livorno 25
Norwalk 25
Phoenix 24
Nanjing 23
Lucca 22
Padova 22
Reggio Nell'emilia 21
Boston 19
Dong Ket 19
New Delhi 19
Poplar 19
Rio de Janeiro 19
Salerno 19
Leawood 18
Messina 18
Cagliari 17
Nuremberg 17
San José 17
San Mateo 17
Sterling 17
Zhengzhou 16
Brooklyn 15
Denver 15
Kunming 15
Venice 15
Belo Horizonte 14
Totale 17.363
Nome #
Effetto della N-acetilcisteina sulla progressione dell'insufficienza renale cronica nel ratto 4.101
Research of Prostate Cancer Urinary Diagnostic Biomarkers by Proteomics: The Noteworthy Influence of Inflammation 1.123
Allopregnanolone serum levels in female migraineurs 731
Relationship of asymmetric dimethylarginine to haemodialysis hypotension 410
Comparison between hydroperoxides and malondialdehyde as markers of acute oxidative injury during hemodialysis 362
Long-term n-acetylcysteine and l-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes 338
Enriched sera protein profiling for detection of non-small cell lung cancer biomarkers. 334
Non-bacterial protein expression in periodontal pockets by proteome analysis 322
Analysis of protein expression in periodontal pocket tissue: a preliminary study 312
Proteomic profiling during atherosclerosis progression: Effect of nebivolol treatment 309
Serum protein changes in a rat model of chronic pain show a correlation between animal and humans 308
Comparison of pregnenolone sulfate, pregnanolone and estradiol levels between patients with menstrually-related migraine and controls: an exploratory study 305
Proteomic analysis of urine in medication-overuse headache patients: possible relation with renal damages 295
Studio degli effetti della LDL aferesi in pazienti affetti da ipercolesterolemia familiare 290
Impairment of 8-iso-PGF(2ALPHA) isoprostane metabolism by dietary conjugated linoleic acid (CLA) 289
Validation of potential candidate biomarkers of drug-induced nephrotoxicity and allodynia in medication-overuse headache 282
Proteomic research of proteins involved in pain expression in an animal model of chronic pain 280
Prooxidant activity of ferrioxamine in isolated rat hepatocytes and linoleic acid micelles 278
Discovery by a proteomic approach of possible early biomarkers of drug-induced nephrotoxicity in medication-overuse headache 262
“VITAMIN E MODULATES BENZOYL PEROXIDE TOXICITY IN HUMAN KERATINOCYTES” 257
New horizon in dialysis depuration: Characterization of a polysulfone membrane able to break the 'albumin wall' 253
Oxidative stress in fibroblasts from patients with pseudoxanthoma elasticum: possible role in the pathogenesis of clinical manifestations 252
Analisi tissutale proteomica della tasca parodontale. Uno studio pilota Periodontal pocket tissue analysis using proteome. A pilot study 251
Can prostatitis to be a confounding parameter in prostatic proteomic profile designation? 250
Proteomic profiling during atherosclerosis progression using SELDI-TOF-MS: Effect of darbepoetin treatment 248
Antioxidant activity of carotenoids: an electron spin resonance study of beta-carotene and lutein interaction with free radicals generated in a chemical system 247
N-Acetylcysteine negatively modulates nitric oxide production in endotoxin-treated rats through inhibition of NF-ĸB activation 244
Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments 244
Proteomic analisys of protein extraction during hemofiltration with on-line endogenous reinfusion (HFR) using different polysulphone membranes 244
High-abundance proteins depletion for serum proteomic analysis: concomitant removal of non-targeted proteins. 241
Inflammation: an important parameter in the search of prostate cancer biomarkers 236
N-Acetylcysteine inhibits in vivo nitric oxide production by inducible nitric oxide synthase 229
Role of oxidative stress in progressive kidney failure 227
Discovery of restless legs syndrome plasmatic biomarkers by proteomic analysis 226
An unusual case of signet ring cell adenocarcinoma of the prostate 226
Comparative proteomic analysis between the gingival crevicular fluid and the corresponding periodontal pocket: a preliminary study 226
Optimizing protein recovery yield from serum samples treated with beads technology. 222
Analisi proteo mica nella neoplasia prostatica: Risultati preliminari e nuove prospettive. 220
Quantificazione del p-cresol solfato nel plasma di pazienti uremici mediante MNR. 220
Effect of alpha-tocopherol and N-acetylcysteine on benzoyl peroxide toxicity in human keratinocytes 218
“Role of NO in hypotension prone dialytic patients” 214
Quantification of p-cresol sulphate in human plasma by selected reaction monitoring. 213
Metabolism of 8-iso-PGF2 alpha isoprostane is impaired by conjugated linoleic acid (CLA) 213
Influence of different hemodialysis membranes on red blood cell susceptibility to oxidative stress 213
Detection of predictive urinary biomarkers of nephropathy in type 1 and type 2 diabetes by proteomic analysis 208
Oxidative stress in renal patients 207
Proteomic serum profile in menstrual-related and post menopause migraine 207
New insights on the pathogenesis of clinical manifestations in Pseudoxathoma elasticum. 206
Urine proteomic analysis in patients with cronic headache and overuse of analgesic drugs: possible relation with renal damage 203
Proteomic Analysis of PTCH1+/- Fibroblast Lysate and Conditioned Culture Media Isolated from the Skin of Healthy Subjects and Nevoid Basal Cell Carcinoma Syndrome Patients. 202
Dehydroepiandrosterone Sulfate, Dehydroepiandrosterone, 5α-Dihydroprogesterone and Pregnenolone: Serum Analysis and Correlation Between Migraine and Non-headache Control Females 202
Proteomic profile of non-bacterial proteins in periodontal pockets: a pilot study. 201
A Proteomic Analysis of Discolored Tooth Surfaces after the Use of 0.12% Chlorhexidine (CHX) Mouthwash and CHX Provided with an Anti-Discoloration System (ADS) 201
Superhighflux therapies for hemodialysis: ultrafiltrate proteomic profile and protein identification by on-chip elution. 197
Effetti della N-acetilcisteina in condizioni di stress ossidativo 195
Nitric oxide and hypotension in haemodialysis patients. 193
Antioxidants modulates benzoyl-peroxide toxicity in human keratinocytes 193
Proteomic profile of retained proteins from hemodiafiltration with on-line endogenous reinfusion (SUPRA) cartridge. 192
“The highly reducing sugar 2-deoxy-d-ribose induces apoptosis in human fibroblasts by reduced glutathione depletion and cytoskeletal disruption” 191
Evaluation of potential cardiovascular risk protein biomarkers in high severity restless legs syndrome 182
Evaluation of a possible relationship between medication-overuse headache and potential renal dysfunctions by a proteomic study on urine samples 181
Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study 181
Detection of serum protein profile changes in atherosclerosis 180
The comparison of the proteomic profile of periodontal pocket and of corresponding gingival crevicular fluid to study periodontal disease biomarkers: feasibility study. biomarkers: feasibility study 179
Quantification of P-cresol sulphate in human plasma of uremic patients by MRM 179
POTENTIAL ROLE OF PROTEOMIC ANALYSIS IN PROSTATE CANCER DIAGNOSIS 178
Oxidative stress and experimental shock 176
Effect of nebivolol treatment on proteomic profiling during atherosclerosis progression. 176
Biomarkers discovery of renal alterations in urine of diabetic patients by proteomic analysis 176
Chronic inflammation in end stage renal disease: markers of oxidative stress and redox modification 176
Evalutation of proteomic profile in menstrually-related migraine 171
Redox regulation, cytokines, and nitric oxide in inflammation 169
Evaluation of proteomic profile in menstrual-related migraine 168
Studio STEPS: Superior Therapies for hemodialysis. Approccio proteomico. 165
Bioactive Glasses in Periodontal Regeneration: Existing Strategies and Future Prospects—A Literature Review 165
Heparin-induced lipoprotein precipitation apheresis in dyslipidemic patients: A multiparametric assessment 164
Proteomic serum profile of female migraineurs 163
The influence of inflammation in the search of discriminatory biomarkers for prostate cancer: a proteomic study 160
Steps Study: Superhighflux therapies for hemodialysis. A proteomic approach. 159
Proteomic profile of retained proteins from hfr cartridge 155
Cytokine and nitric oxide redox regulation in vivo 154
Plasma antioxidants modifications during haemodialysis 146
Dehydroepiandrosterone sulfate, dehydroepiandrosterone, 5α-dihydroprogesterone and pregnenolone in women with migraine: analysis of serum levels and correlation with age, migraine years and frequency 144
Proteomic analysis of PTCH1+/- fibroblast lysate and conditioned culture media isolated from the skin of healthy subjects and Nevoid Basal Cell Carcinoma Syndrome (NBCCS) patients. 143
Metabolism of 8-iso-PGF2 alpha and conjugated linoleic acid (CLA) in vivo and in X-adrenoleukodystrophy fibroblast. 143
Proteomic analysis of proteins adsorbed by resin cartridge filter during hemodiafitration with online endogenous reinfusion. 141
PROTEOMICS AS DIAGNOSTIC MARKERS 138
Diagnostic proteomic markers to detect kidney diseases 136
Free radical induced oxidative protein modification in kidney diseases: proteomic detection 133
Influence of tooth-brushing on early healing after access flap surgery: A randomized controlled preliminary study 131
Urinary proteomics reveals promising biomarkers in menstrually related and post-menopause migraine 128
Urinary proteomics in biomarker discovery of kidney-related disorders: Diabetic nephropathy and drug-induced nephrotoxicity in chronic headache 127
Validation of prostate cancer biomarkers and inflammation: a proteomic study 121
Erratum to: Proteomic analysis of protein extraction during hemofiltration with on-line endogenous reinfusion (HFR) using different polysulphone membranes [JMater Sci:MaterMed, 25, (2014) 2691-2698, DOI 10.1007/s10856-014-5290-5] 121
Urinary proteomic profiles of prostate cancer with different risk of progression and correlation with histopathological features 119
Proteomics to identify free radical induced oxidative protein modifications as biomarkers associated to type 2 diabetic nephropathy 117
No evidences of oxidative injury associated with slow intravenous administration of ferric gluconate during haemodialysis 116
Proteomic analysis to discover early urinary biomarkers of type 2 diabetic nephropathy 116
Role of nitric oxide generating pathway in haemodialysis hypotension 113
Markers of oxidative stress and antioxidant status in haemodialysis patients 113
Totale 25.966
Categoria #
all - tutte 93.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.317 0 0 0 0 0 121 151 287 82 327 239 110
2021/20222.118 66 184 167 440 45 77 91 106 217 156 330 239
2022/20232.978 221 307 222 272 291 415 111 298 342 113 208 178
2023/20244.125 105 173 218 271 426 547 824 612 140 342 190 277
2024/20256.232 330 251 237 477 1.102 846 488 353 543 260 575 770
2025/20263.977 490 282 575 984 1.458 188 0 0 0 0 0 0
Totale 26.981